Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Nimodipine

U.S. FDA Requirements: Nimodipine

Pharmaceutical / Drug Definition : Inhibits calcium transport into vascular smooth muscle cells, suppressing contractions; also dilates coronary and cerebral arteries

Registrar Corp assists Nimodipine companies with:

  • FDA Registration Nimodipine
  • FDA Listing Nimodipine
  • FDA Label Requirements and Exceptions Nimodipine
  • FDA Import Information Nimodipine
  • FDA Detentions Nimodipine (Nimodipine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Nimodipine (Nimodipine Suppliers)
       - Processors Nimodipine
       - Repackers Nimodipine
       - Relabelers Nimodipine
       - Exporters Nimodipine
       - Importers Nimodipine
For more information about Nimodipine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco